Commercialization: Page 14

PharmaVoice Team/PharmaVoice

Q&A

Last Word

Six Keys to Beating the Odds and Achieving Startup Success Sharon Cunningham, Co-founder and CEO of Shorla Pharma, details the six steps she and her partner undertook to launch a successful biopharma company. PV: What was it like starting up Shorla Pharma? Cunningham: Starting your own c...
By Sharon Cunningham • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

SHOWCASE: Supply Chain Management: The Supply Chain: Risks and Opportunities

COVID-19 caused shockwaves throughout the global supply chain of every industry. For the pharmaceutical industry, the pandemic highlighted the fragility of the supply chain and the importance of being able to adjust to demand in a changed environment. The COVID-19 pandemic has demonstrated that c...
By PharmaVoice Team • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

Solving Today's Patient-Centric Supply Chains

Precision oncology, CAR-T cell therapy, gene therapy, CRISPR-Cas9 —scientific advances in the space of cell and gene therapy have made a significant impact on patient care. Biopharma company pipelines are developing advanced treatments at an inspiring pace. Even amid the ongoing COVID-19 pandemic...
By Joe DePinto • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

Virtual Trials: Navigating Change and Avoiding Blinds Spots

As 2020 draws to a close, we reflect on the changes we have had to make in all facets of our lives due to the pandemic. Some were overdue and some are here to stay. Some were easy to adopt and others we resisted. Change of any sort, positive or negative, is known to be one of life’s great stresso...
By Kenneth G. Faulkner • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

Personal Technology and Artificial Intelligence Will Provide for Better Health Outcomes

More and more, pharmaceutical companies are continuing to leverage wearable technology to not only track patient information and vitals, but also track their behavior over time. When a patient’s vitals are taken at a medical facility, only a brief window of data is recorded and monitored. With we...
By Juan Garcia • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

Telehealth: Ready or Not — <del>Here it Comes</del>… It's Here to Stay

Our world is changing more rapidly than ever before, but certain constants remain imperative in the healthcare arena — human connection and access to education. Healthcare professionals (HCPs) need to be able to connect with their patients to properly assess their conditions. HCPs need access to ...
By Christine Molbury • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

The Next Chapter for Real World Evidence: Validating Data with the Patient Voice

In June 2020, in accordance with the 21st Century Cures Act of 2016 and the Prescription Drug User Fee Act (PDUFA), the U.S. Food and Drug Administration (FDA) launched Project Patient Voice. This patient-focused drug development initiative facilitates systematic approaches to collecting and usin...
By Ramita Tandon • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

COVID-19: Silver Linings

COVID-19 has stretched our industry to adjust to all types of new “normals," yet amid all of the disruption and loss of life, there are pockets of light that are expected to lift the life sciences and its people to new heights. Of all the industries that have been impacted across the globe, the l...
By Taren Grom • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

Age of the Machine: The Expanded Role of AI in Pharma

AI and machine learning have the potential to transform the life-sciences industry, but barriers around implementation, process, and regulatory uncertainty must be overcome first. Artificial intelligence and machine learning are very much part of the pharmaceutical landscape today and are expecte...
By Kim Ribbink • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

Breaking Glass: Driving Diversity, Equity, and Inclusion

As companies grapple with an emotional year in terms of the pandemic and racial inequality, efforts to address diversity and inclusion are gaining momentum. When Joe Biden and Kamala Harris won the 2020 U.S. presidential election, it signaled a huge leap forward for diversity: the first woman Vic...
By Kim Ribbink • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

Commanders & Chiefs: Chief Experience Officers

Chief experience officers are influencing the strategic direction of their companies to address the needs and wants of their customers. Julie Adrian Customer Focus “Get closer than ever to your customers. So close that you tell them what they need well before they realize it themselves." This quo...
By PharmaVoice Team • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

What Life Sciences Leaders Say During the Pandemic: 10 Key Takeaways

We are in a global pandemic that is exposing major issues in the commercial environment in which healthcare companies operate, with changes that are completely altering the landscape for the long term. Our 3rd Annual Leaders in Life Sciences Roundtable consisted of eight industry leaders with div...
By Edward John Allera • Nov. 16, 2020
PharmaVoice Team/PharmaVoice

Letter from the Editor

Is the industry ready for an AI revolution? We hooked into AI’s potential impact on the life-sciences industry a couple of years ago. We were early enthusiasts, but by no means the first to grasp the importance of the technology on everything from drug innovation to commercial strategies. We even...
By Taren Grom • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

Upfront

Takeda’s Innovators in Science Award Takeda Pharmaceuticals and the New York Academy of Sciences are drawing attention to the urgent needs of patients worldwide affected by an estimated 7,000 rare diseases. The 2020 Innovators in Science Award recognizes scientists from around the globe for their...
By PharmaVoice Team • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

HealthTech

Organ-on-a-Chip Transforms Drug Development Trend Watch: Healthtech Applications Run the Gamut from Chip Technology to EHRs, to Electronic Skin and Clinical Trials Draper’s Ex Vivo Immuno-oncology Dynamic Environment for Tumor biopsies (EVIDENT) is a microfluidic platform that maintains tumor fra...
By PharmaVoice Team • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

Artificial Intelligence

BenevolentAI Validates Baricitinib as Treatment for COVID-19 Trend Watch: AI solutions span counseling, selfies, biopsies and drug discovery London-based BenevolentAI has reported that data released from a large scale randomized clinical trial, sponsored by the National Institute of Allergy and ...
By PharmaVoice Team • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

Creative Executions

Creative thinking inspires ideas. Ideas inspire change. — Barbara Januszkiewicz In the new-ish omnichannel world of advertising that includes print, TV, social media, etc., great creative based on great ideas, good data, and a fearless approach to ideation is the lynchpin that leads to great camp...
By Taren Grom • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

Commercial Influencers

Influencers have the power to positively change the status quo because of their authority, knowledge, position, or relationship with their audience. According to the global consultancy Evaluate, the impact of COVID-19 has so far wiped $7.85 billion off forecasts for biopharma sales in 2020, with ...
By PharmaVoice Team • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

Roshawn Blunt — Optimizing a Strategic Plan

Given cell and gene therapies are typically personalized medicines, they come with outlier pricing and other unique commercialization challenges that differ from other large and small molecule therapies. Roshawn Blunt, a respected biotech consultant, was inspired by President John Adams, who in 1...
By Roshawn Blunt • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

Greg Skalicky — Understanding the Commercial Lifecycle

By building a complete commercial platform, we are able to take a broad view of how market and product complexities impact operations. With a wide breadth of clinical and commercial experience, Greg Skalicky, chief revenue officer of EVERSANA, has a keen understanding of the entire product lifecy...
By Greg Skalicky • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

SHOWCASE: Artificial Intelligence: Driving Drug Innovation With AI

The global AI market has been showing rapid growth as major pharmaceutical and medical technology companies invest heavily in internal and external AI partnerships. According to some reports, more than 50% of executives expect broad scale AI adoption by 2025. Further, revenue generated through AI...
By PharmaVoice Team • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

Case Study: Leveraging AI for Meaningful Clinical Trials

Clinical trial sponsors seeking to develop new drugs and therapies face unique challenges, particularly when it comes to understanding patient dosing and response to therapy. This aspect can be difficult, as patients often: Do not take their medicine regularly, or at all Take creative measures to...
By Rich Christie • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

How AI Can Improve Understanding of Patient's Behavior and Symptoms

Running and managing clinical trials, at the most basic level, is about creating a foundation to get the best possible data. While a great deal of thought goes into recruiting the right patients and developing the most effective protocols, initiatives designed to improve the experience for the pa...
By Michelle Marlborough • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

5 Steps to Intelligent Omnichannel Engagement

The future of HCP engagement in the post-pandemic world isn’t clear. But in the wake of pharma’s forced digital migration, the need for an effective omnichannel strategy is. Luckily, most commercial teams already have a strong data and analytics infrastructure in place and are beginning to activa...
By Matthew Van Wingerden • Oct. 1, 2020
PharmaVoice Team/PharmaVoice

Technology-Driven Pharmacovigilance Operations

Improving Data Quality and Compliance while Reducing Cost with AI Traditionally, the pharmacovigilance (PV) function has been responsible for collecting, assessing, and reporting safety information to health authorities, sites, and other stakeholders. Companies have invested in safety systems to ...
By Dinesh Kasthuril • Oct. 1, 2020